ViQi News
April 2, 2024 — ViQi attends World Vaccine Congress in Washington D.C. too showcase AVIA paper and poster.
February 8, 2024 — ViQi attends SLAS (Society for Laboratory Automation & Screening) conference in Boston and showcases ViQi's ai-based automated image analysis, AutoHCS, with a poster as well as two collaboration posters with Anatomic Incorporated and Saguaro Biosciences.
December 7, 2023 — ViQi’s strategic partner, PharmaNest, publishes a paper in Liver International. Their innovative product, FibroNest™, utilizes advanced image analysis on the ViQi, Inc platform to provide detailed quantification of histological traits, offering a comprehensive approach to liver fibrosis phenotyping and severity scoring.
October 30, 2023 — ViQi attends Society of Biomolecular Imaging and Informatics (SBI2) Conference in Boston, showcasing technological advancements of AI for cell based imaging at a ViQi booth, during a speaking opportunity with Teresa Findley, PhD, through a ViQi poster of AutoHCS using the JUMP-CP dataset, and in collaboration with both Saguaro Technologies, Yokogawa Life Science, and Sunnybrook Research Institute.
July 14, 2023 — ViQi and collaborators announce publication of paper, "A rapid, high-throughput, viral infectivity assay using automated brightfield microscopy with machine learning," in SLAS Technology.
May 24, 2023 — ViQi collaborates with Saguaro Technologies using our automated high-content screening assay (AutoHCS) to cluster compounds by their resulting phenotype.
April 27, 2023 — ViQi demonstrates its AutoHCS analysis tools using the JUMP Cell Painting datasets.
February 28, 2023 — Dr. Ilya Goldberg presents on AutoHCS at SLAS 2O23 Conference.
February 2, 2023 — ViQi featured as a Case Study with our eQMS vendor, Qualio.
January 18, 2023 — ViQi at Innovation AveNEW at SLAS 2023! We’re excited to share that ViQi was accepted as an Innovation AveNEW company at SLAS23 in San Diego in February, a program designed for emerging companies in the life sciences space.
September 15, 2022 — ViQi, Inc. announces Pascal Bamford, Ph.D. and Timothy Spicer, Ph.D. have joined the board of directors and scientific advisory board, respectively.
July 27, 2022 — ViQi is awarded the DOE grant SBIR Phase IIB: Interactive Visualization of Multi-Terabyte Datasets on Commodity Hardware
July 17, 2022 —ViQi and collaborators exhibit poster "AI-based Infectivity Assay using Brightfield Microscopy" at 41st Annual Meeting of the American Society of Virology
April 7, 2022 — ViQi and collaborators exhibit a poster “AI-based Infectivity Assay using Brightfield Microscopy” at Viruses 2022: At the Leading Edge of Virology Research virtual conference
April 1, 2022 — ViQi is awarded the NSF grant SBIR Phase II: Machine learning for Rapid Automated Viral Infectivity Assays
March 28, 2022 — ViQi team and collaborators submit the publication “A Rapid, High Throughput, Viral Infectivity Assay using Automated Brightfield Microscopy with Machine Learning”.
March 23, 2022 — ViQi CSO Dr. Ilya Goldberg presented at ICAR 2022 a talk titled “Automated brightfield microscopy and AI to develop rapid high throughput infectivity assays for screening antiviral drugs and monitoring vaccine effectiveness against emerging variants”.
February 5-9, 2022 — ViQi and collaborators exhibit a poster “High Throughput Viral Infectivity Assays for Vaccine and Antiviral Drug Development Using Automated Brightfield Microscopy and Analysis by Machine Learning” at SLAS 2022 in Boston, MA
September 2021 — ViQi receives sub-award in HydroGEN University of Arizona-led project funded by the National Science Foundation’s Convergence Accelerator Project to model national water resources using machine learning
August 2021 — ViQi recruits 3 academic and 4 industry collaborators to test infectivity assay on 12 different viruses
July 2021 — ViQi launches FibroNest 3.0, which includes additional capabilities to quantify common pathology parameters (i.e. steatosis, inflammation and ballooning) associated with fibrosis for the study of NASH and other fibrotic conditions in drug discovery and drug development.
March 15, 2020 — ViQi launches AI for HCA pilot screen partner search
January 2021 — As part of an NSF Phase I grant, ViQi successfully trains an AI to identify infected from uninfected cells in brightfield for human coronavirus 229E
September 2, 2020 — ViQi is awarded an NSF grant to test AI on plaque assays, reported by the Santa Barbara News-Press
September, 2020 (on demand) — ViQi exhibits a poster AI-based analysis of complex biological phenotypes at LabRoots SBI² High Content 2020 coauthored with Molecular Devices
July 16, 2020 — ViQi hosted the webinar Practical Applications for AI in High-Content Analysis: Dose-Response and Quantitative Assays with speaker Dr Ilya Goldberg
June 11, 2020 — ViQI Appoints Kathy Yeung as Chief Executive Officer
April 16, 2020 — ViQi hosted the webinar, “How to Use AI for Classifying Cell Types & Phenotypes in the Cloud: The Live/Dead Assay” with speaker Dr. Ilya Goldberg
April 9, 2020 — ViQi, Inc. Appoints Dr. Ilya Goldberg as Chief Science Officer
March 1, 2020 — ViQi, Inc. sponsors Molecular Med Tri-Conference in San Francisco, March 1st - 4th
January 25, 2020 — ViQi, Inc. sponsors the Society for Laboratory Automation and Screening (SLAS) conference in San Diego, 25th - 29th
December 5, 2019 — ViQi, Inc. joins the California Life Sciences Association
November 6, 2019 — ViQi, Inc. invited to speak at the San Diego Innovation Council Showcase
September 24, 2019 — PharmaNest Launches FibroNest, the First Multivendor Image Analysis and Translational Platform for the Assessment of the Severity and Progression of Fibrosis in NASH (ViQi Partner)
August 19, 2019 — ViQi, Inc. sponsors Next Generation Dx Summit in Washington, DC August 19th- August 23rd
June 18, 2019 — Scientific Image & Data Analysis Software Provider ViQi, Inc. Awarded SBIR Phase II Funding From U.S. Department Of Energy
June 17, 2019 — ViQi, Inc. sponsors World Pharma Week in Boston, June 17th - June 20th
March 11, 2019 — ViQi, Inc. sponsors Molecular Med Tri-Conference in San Francisco, March 11th - March 13th
Keep in touch and follow us on LinkedIn.